All atropine Articles
-
5.8KResearch ReviewEfficacy of Combined OrthoK and 0.01% Atropine in Myopia Control
March 1, 2022 By Linh Hoang, MD, MSc, and Huy Tran, MD, PhD Atropine and orthokeratology are effective in slowing myopia. Despite...
-
1.2KClinicalRecent Updates on Combination Treatments for Myopia Control
March 1, 2022 By Dr. Pavan K. Verkicharla and Mr. Swapnil Thakur It is important to note that there will be non-responders...
-
2.5KResearch ReviewThree-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression
January 17, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The aim of this clinical trial conducted in Hong Kong on...
-
8.2KClinicalOvernight Orthokeratology for Myopia: What Does the Evidence Say?
No one treatment is 100% effective at slowing the rate of myopia progression.
-
2.7KResearch ReviewSide Effects of Topical Atropine in Caucasian Myopic Children
April 15, 2021 By Dwight Akerman, OD, FAAO, FBCLA The LAMP study (low-concentration atropine for myopia progression) from Hong Kong addressed safety...
-
5.6KPharmaceutical InterventionsLow-Concentration Atropine for Myopia Progression (LAMP)
A summary of the LAMP Study results
-
9.3KClinicalTopical Atropine for Myopia Management: The Latest Research
When should one start atropine treatment for myopes?
-
3.3KClinicalStarting Myopia Management Early Yields Greatest Outcomes
July 15, 2021 By Melanie Frogozo, OD, FAAO, Alamo Eye Care , San Antonio, Texas To give children the greatest chance of...
-
2.9KEditor’s PerspectivePracticing at the Highest Level
June 1, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA When I speak with eye care professionals about childhood myopia, it is...
-
4.5KResearch ReviewThe Efficacy of Atropine Combined with Orthokeratology
March 1, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA Previous clinical studies have found that topical low-dose atropine can slow axial...
-
5.2KClinicalPrescribing A Complete Myopia Management System
April 15, 2021 By Keith Wan, OD, Scripps Poway Eyecare & Optometry The future looks bright for myopia management. If you’re in...
-
6.4KClinicalCombination Strategies for Myopia Management
April 1, 2021 By Huy Tran, MD, and Padmaja Sankaridurg, PhD “Should a combination strategy be routinely presented as an option for...
-
4.4KResearch ReviewA Three-Year Study of Atropine Treatment in European Children
March 1, 2021 By Thao Ha, MD Hai Yen Vision Institute Collaborating Scientist, Brien Holden Vision Institute Myopia significantly impacts human health...
-
4.4KLatest Myopia NewsNevakar and Théa Enter Licensing Agreement for NVK-002 Atropine in Europe
February 1, 2021 BRIDGEWATER, N.J. and Clermont-Ferrand, France – Nevakar Inc. and Laboratoires Théa entered an exclusive licensing agreement for the commercialization...
-
3.5KLatest Myopia NewsEye Health Organizations Unveil Recommendations in Response to Myopia Epidemic
January 11, 2021 JACKSONVILLE, Florida – Johnson & Johnson Vision announced new guidance for eye care professionals to assess, monitor, and treat...
-
2.8KLatest Myopia NewsThe Compounding Center Offers Patented Atropine Eye Dropper
December 23, 2020 LEESBURG, Virigina – The Compounding Center, a compounding pharmacy specializing in customized, compounded medications for human and animal patients,...
-
2.7KLatest Myopia NewsFirst Patient Completes Three-Year Enrollment in Nevakar’s Phase III CHAMP Study of NVK-002
November 9, 2020 Nevakar Inc., a biopharmaceutical company developing multiple products in the ophthalmic and injectable areas, announced today that the first...
-
2.7KLatest Myopia News
Nevakar/Zhaoke Ophthalmology Enter Licensing Agreement for NVK-002 Atropine
October 20, 2020 Bridgewater, NJ (USA) and Hong Kong S.A.R., October 20, 2020 – Nevakar Inc., a privately held, late-stage, biopharmaceutical company...
-
8.0KClinicalMechanism of Action of Atropine in Controlling Myopia Progression
October 1, 2020 By Huy Tran, MD, and Thao Ha, MD Myopia is the most common refractive error worldwide and is estimated...
-
2.3KLatest Myopia News
Eyenovia Launches Website to Help Parents Find Its CHAPERONE Study
August 11, 2020 Eyenovia, which in June enrolled its first patient in its Phase 3 CHAPERONE study of progressive myopia, this month...
-
13.1KClinicalTopical Low-Dose Atropine: A Global Perspective
June 24, 2020 By Dwight Akerman, OD, MBA, FAAO, FBCLA Chief Medical Editor, Review of Myopia Management The use of atropine to...
-
5.1KLatest Myopia NewsEyenovia Developing a Microdose Treatment for Delivering Atropine
June 12, 2020 The clinical-stage ophthalmic biopharmaceutical company Eyenovia is developing a microdose treatment that is designed to improve the delivery of...
-
3.3KPharmaceutical Interventions
How Does Atropine Slow Myopia Progression?
June 1, 2020 By Dwight Akerman, OD, MBA, FAAO Myopia is characterized by excessive axial elongation because of an increase in the...
-
7.0KClinicalMyopia Management in the Era of COVID-19
June 1, 2020 By Melanie Frogozo, OD In late 2019 a novel coronavirus, SARS-CoV-2, and its associated disease COVID-19, emerged in China...
-
3.5KPharmaceutical InterventionsManaging Myopia with Low-Dose Atropine Eye Drops
December 1, 2020 By Dwight Akerman, OD, MBA, FAAO, FBCLA In this randomized, placebo-controlled, double-masked study, researchers tested the safety and effectiveness...
-
9.3KClinical
One Drop into Each Eye at Bedtime: What Could be Simpler?
May 1, 2020 By Laura Kirkeby, CO The use of atropine has been known to slow the progression of myopia for many...
-
2.0KLatest Myopia NewsWebinar: Atropine – The Science and Clinical Treatment
April 27, 2020 In this webinar Jeffrey Cooper, MS, OD, FAAO, FCOVD, talks about both the scientific and clinical aspects of the...